The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Transcriptomics Technologies-Global Market Insights and Sales Trends 2025
Synopsis
Transcriptomic incorporates the exploration and assortment of transcriptomes and finds diverse applications, chiefly in molecular genetics. The global transcriptomic market could see a whole lot of instances of new product launch. For example, Trio RNA-Seq launched by NuGEN Technologies, Inc. is particularly suited for low abundance transcripts applications as it offers an extremely sensitive whole transcriptomic solution. This innovation embodies three powerful technologies, viz. single primer isothermal amplification (SPIA), DimerFree, and AnyDeplete, for performing high sensitivity ribonucleic acid (RNA) analysis.
The global Transcriptomics Technologies market size is expected to reach US$ 4503.9 million by 2029, growing at a CAGR of 2.5% from 2023 to 2029. The market is mainly driven by the significant applications of Transcriptomics Technologies in various end use industries. The expanding demands from the Clinical Diagnostics, Drug Discovery and Research, Bioinformatics and Comparative Transcriptomics Studies, are propelling Transcriptomics Technologies market. Microarrays, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Polymerase Chain Reaction (PCR) segment is estimated at % CAGR for the next seven-year period.
North America is the largest consumption place, with a consumption market share nearly 55% . Following North America, Europe is the second largest consumption place with the consumption market share of 27% .The key manufacturers are Thermo Fisher Scientif
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Transcriptomics Technologies, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Transcriptomics Technologies market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Transcriptomics Technologies market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Transcriptomics Technologies sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Transcriptomics Technologies covered in this report include Affymetrix, Inc., Thermo Fisher Scientific, Agilent Technologies, F-Hoffmann La Roche Ltd., Illumina, Inc., Life Technologies Corporation, Qiangen N.V., LC Sciences and Sigma-Aldrich Corp, etc.
The global Transcriptomics Technologies market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Affymetrix, Inc.
Thermo Fisher Scientific
Agilent Technologies
F-Hoffmann La Roche Ltd.
Illumina, Inc.
Life Technologies Corporation
Qiangen N.V.
LC Sciences
Sigma-Aldrich Corp
Danaher Corp
Global Transcriptomics Technologies market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Transcriptomics Technologies market, Segment by Type:
Microarrays
Polymerase Chain Reaction (PCR)
Gene Regulation Technologies
Next Generation Sequencing (NGS)
Global Transcriptomics Technologies market, by Application
Clinical Diagnostics
Drug Discovery and Research
Bioinformatics
Comparative Transcriptomics Studies
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Transcriptomics Technologies companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Transcriptomic incorporates the exploration and assortment of transcriptomes and finds diverse applications, chiefly in molecular genetics. The global transcriptomic market could see a whole lot of instances of new product launch. For example, Trio RNA-Seq launched by NuGEN Technologies, Inc. is particularly suited for low abundance transcripts applications as it offers an extremely sensitive whole transcriptomic solution. This innovation embodies three powerful technologies, viz. single primer isothermal amplification (SPIA), DimerFree, and AnyDeplete, for performing high sensitivity ribonucleic acid (RNA) analysis.
The global Transcriptomics Technologies market size is expected to reach US$ 4503.9 million by 2029, growing at a CAGR of 2.5% from 2023 to 2029. The market is mainly driven by the significant applications of Transcriptomics Technologies in various end use industries. The expanding demands from the Clinical Diagnostics, Drug Discovery and Research, Bioinformatics and Comparative Transcriptomics Studies, are propelling Transcriptomics Technologies market. Microarrays, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Polymerase Chain Reaction (PCR) segment is estimated at % CAGR for the next seven-year period.
North America is the largest consumption place, with a consumption market share nearly 55% . Following North America, Europe is the second largest consumption place with the consumption market share of 27% .The key manufacturers are Thermo Fisher Scientif
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Transcriptomics Technologies, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Transcriptomics Technologies market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Transcriptomics Technologies market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Transcriptomics Technologies sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Transcriptomics Technologies covered in this report include Affymetrix, Inc., Thermo Fisher Scientific, Agilent Technologies, F-Hoffmann La Roche Ltd., Illumina, Inc., Life Technologies Corporation, Qiangen N.V., LC Sciences and Sigma-Aldrich Corp, etc.
The global Transcriptomics Technologies market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Affymetrix, Inc.
Thermo Fisher Scientific
Agilent Technologies
F-Hoffmann La Roche Ltd.
Illumina, Inc.
Life Technologies Corporation
Qiangen N.V.
LC Sciences
Sigma-Aldrich Corp
Danaher Corp
Global Transcriptomics Technologies market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Transcriptomics Technologies market, Segment by Type:
Microarrays
Polymerase Chain Reaction (PCR)
Gene Regulation Technologies
Next Generation Sequencing (NGS)
Global Transcriptomics Technologies market, by Application
Clinical Diagnostics
Drug Discovery and Research
Bioinformatics
Comparative Transcriptomics Studies
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Transcriptomics Technologies companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Transcriptomics Technologies
1.1 Transcriptomics Technologies Market Overview
1.1.1 Transcriptomics Technologies Product Scope
1.1.2 Transcriptomics Technologies Market Status and Outlook
1.2 Global Transcriptomics Technologies Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Transcriptomics Technologies Market Size by Region (2018-2029)
1.4 Global Transcriptomics Technologies Historic Market Size by Region (2018-2023)
1.5 Global Transcriptomics Technologies Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Transcriptomics Technologies Market Size (2018-2029)
1.6.1 North America Transcriptomics Technologies Market Size (2018-2029)
1.6.2 Europe Transcriptomics Technologies Market Size (2018-2029)
1.6.3 Asia-Pacific Transcriptomics Technologies Market Size (2018-2029)
1.6.4 Latin America Transcriptomics Technologies Market Size (2018-2029)
1.6.5 Middle East & Africa Transcriptomics Technologies Market Size (2018-2029)
2 Transcriptomics Technologies Market by Type
2.1 Introduction
2.1.1 Microarrays
2.1.2 Polymerase Chain Reaction (PCR)
2.1.3 Gene Regulation Technologies
2.1.4 Next Generation Sequencing (NGS)
2.2 Global Transcriptomics Technologies Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Transcriptomics Technologies Historic Market Size by Type (2018-2023)
2.2.2 Global Transcriptomics Technologies Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Transcriptomics Technologies Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Transcriptomics Technologies Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Transcriptomics Technologies Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Transcriptomics Technologies Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Transcriptomics Technologies Revenue Breakdown by Type (2018-2029)
3 Transcriptomics Technologies Market Overview by Application
3.1 Introduction
3.1.1 Clinical Diagnostics
3.1.2 Drug Discovery and Research
3.1.3 Bioinformatics
3.1.4 Comparative Transcriptomics Studies
3.2 Global Transcriptomics Technologies Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Transcriptomics Technologies Historic Market Size by Application (2018-2023)
3.2.2 Global Transcriptomics Technologies Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Transcriptomics Technologies Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Transcriptomics Technologies Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Transcriptomics Technologies Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Transcriptomics Technologies Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Transcriptomics Technologies Revenue Breakdown by Application (2018-2029)
4 Transcriptomics Technologies Competition Analysis by Players
4.1 Global Transcriptomics Technologies Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Transcriptomics Technologies as of 2022)
4.3 Date of Key Players Enter into Transcriptomics Technologies Market
4.4 Global Top Players Transcriptomics Technologies Headquarters and Area Served
4.5 Key Players Transcriptomics Technologies Product Solution and Service
4.6 Competitive Status
4.6.1 Transcriptomics Technologies Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Affymetrix, Inc.
5.1.1 Affymetrix, Inc. Profile
5.1.2 Affymetrix, Inc. Main Business
5.1.3 Affymetrix, Inc. Transcriptomics Technologies Products, Services and Solutions
5.1.4 Affymetrix, Inc. Transcriptomics Technologies Revenue (US$ Million) & (2018-2023)
5.1.5 Affymetrix, Inc. Recent Developments
5.2 Thermo Fisher Scientific
5.2.1 Thermo Fisher Scientific Profile
5.2.2 Thermo Fisher Scientific Main Business
5.2.3 Thermo Fisher Scientific Transcriptomics Technologies Products, Services and Solutions
5.2.4 Thermo Fisher Scientific Transcriptomics Technologies Revenue (US$ Million) & (2018-2023)
5.2.5 Thermo Fisher Scientific Recent Developments
5.3 Agilent Technologies
5.3.1 Agilent Technologies Profile
5.3.2 Agilent Technologies Main Business
5.3.3 Agilent Technologies Transcriptomics Technologies Products, Services and Solutions
5.3.4 Agilent Technologies Transcriptomics Technologies Revenue (US$ Million) & (2018-2023)
5.3.5 F-Hoffmann La Roche Ltd. Recent Developments
5.4 F-Hoffmann La Roche Ltd.
5.4.1 F-Hoffmann La Roche Ltd. Profile
5.4.2 F-Hoffmann La Roche Ltd. Main Business
5.4.3 F-Hoffmann La Roche Ltd. Transcriptomics Technologies Products, Services and Solutions
5.4.4 F-Hoffmann La Roche Ltd. Transcriptomics Technologies Revenue (US$ Million) & (2018-2023)
5.4.5 F-Hoffmann La Roche Ltd. Recent Developments
5.5 Illumina, Inc.
5.5.1 Illumina, Inc. Profile
5.5.2 Illumina, Inc. Main Business
5.5.3 Illumina, Inc. Transcriptomics Technologies Products, Services and Solutions
5.5.4 Illumina, Inc. Transcriptomics Technologies Revenue (US$ Million) & (2018-2023)
5.5.5 Illumina, Inc. Recent Developments
5.6 Life Technologies Corporation
5.6.1 Life Technologies Corporation Profile
5.6.2 Life Technologies Corporation Main Business
5.6.3 Life Technologies Corporation Transcriptomics Technologies Products, Services and Solutions
5.6.4 Life Technologies Corporation Transcriptomics Technologies Revenue (US$ Million) & (2018-2023)
5.6.5 Life Technologies Corporation Recent Developments
5.7 Qiangen N.V.
5.7.1 Qiangen N.V. Profile
5.7.2 Qiangen N.V. Main Business
5.7.3 Qiangen N.V. Transcriptomics Technologies Products, Services and Solutions
5.7.4 Qiangen N.V. Transcriptomics Technologies Revenue (US$ Million) & (2018-2023)
5.7.5 Qiangen N.V. Recent Developments
5.8 LC Sciences
5.8.1 LC Sciences Profile
5.8.2 LC Sciences Main Business
5.8.3 LC Sciences Transcriptomics Technologies Products, Services and Solutions
5.8.4 LC Sciences Transcriptomics Technologies Revenue (US$ Million) & (2018-2023)
5.8.5 LC Sciences Recent Developments
5.9 Sigma-Aldrich Corp
5.9.1 Sigma-Aldrich Corp Profile
5.9.2 Sigma-Aldrich Corp Main Business
5.9.3 Sigma-Aldrich Corp Transcriptomics Technologies Products, Services and Solutions
5.9.4 Sigma-Aldrich Corp Transcriptomics Technologies Revenue (US$ Million) & (2018-2023)
5.9.5 Sigma-Aldrich Corp Recent Developments
5.10 Danaher Corp
5.10.1 Danaher Corp Profile
5.10.2 Danaher Corp Main Business
5.10.3 Danaher Corp Transcriptomics Technologies Products, Services and Solutions
5.10.4 Danaher Corp Transcriptomics Technologies Revenue (US$ Million) & (2018-2023)
5.10.5 Danaher Corp Recent Developments
6 North America
6.1 North America Transcriptomics Technologies Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Transcriptomics Technologies Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Transcriptomics Technologies Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Transcriptomics Technologies Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Transcriptomics Technologies Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Transcriptomics Technologies Market Dynamics
11.1 Transcriptomics Technologies Industry Trends
11.2 Transcriptomics Technologies Market Drivers
11.3 Transcriptomics Technologies Market Challenges
11.4 Transcriptomics Technologies Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
